New York, NY, 21 April 2015 - Progyny, Inc., the new combined entity of Auxogyn, Inc. and Fertility Authority, LLC, announced that it has secured additional capital from investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech, SR One and Merck KGaA, Darmstadt, Germany Serono Ventures. The funding will enable the company to accelerate efforts to provide patients the best fertility outcomes by aligning science, technology, clinics and patients.
